Efficacy of photobiomodulation therapy in the management of oral mucositis in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials

被引:1
|
作者
Shen, Bin [1 ]
Zhou, Yaoying [1 ]
Wu, Dongping [2 ,3 ]
Liu, Jianjiang [2 ,3 ]
机构
[1] Shaoxing Peoples Hosp, Dept Nursing, Shaoxing, Peoples R China
[2] Shaoxing Peoples Hosp, Dept Radiotherapy, Shaoxing, Peoples R China
[3] Shaoxing Peoples Hosp, Dept Radiotherapy, 568 Zhongxing North Rd, Shaoxing 312000, Zhejiang, Peoples R China
关键词
concurrent radiotherapy; head and neck cancer; meta-analysis; oral mucositis; photobiomodulation; LEVEL LASER THERAPY; CONCURRENT CHEMORADIOTHERAPY; RADIOTHERAPY; PREVENTION; CHEMOTHERAPY; LLLT;
D O I
10.1002/hed.27655
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Numerous studies have examined the effectiveness of photobiomodulation therapy (PBMT) in reducing chemoradiotherapy (CRT)-induced oral mucositis (OM) in patients with head and neck cancer (HNC). Despite this, there is an urgent need to update the meta-analyses on this topic. This meta-analysis aims to explore the impact of PBMT on CRT-induced OM in these patients. We conducted a systematic search in PubMed, Embase, Cochrane, LILACS, and Web of Science from January 2000 to October 2023. This search focused on randomized controlled trials (RCTs) that assessed the effects of PBMT on CRT-induced OM. The study included a total of 14 RCTs encompassing 869 patients with HNC. The incidence of OM in the PBMT group was significantly lower from the second week onwards compared to the control group (RR = 0.49, CI = 0.25-0.97, I-2 = 71%, p = 0.04), and this was present until the seventh week (RR = 0.77, CI = 0.61-0.99, I-2 = 89%, p = 0.04). Furthermore, the occurrence of severe mucositis in the PBMT group decreased from the third week (RR = 0.51, CI = 0.29-0.90, I-2 = 12%, p = 0.02) until the conclusion of the intervention (RR = 0.45, CI = 0.24-0.85, I-2 = 80%, p = 0.01). Additionally, PBMT showed beneficial effects in alleviating OM-related pain (WMD = -1.09, 95% CI = -1.38 to -0.880, I-2 = 13%, p < 0.00001). The use of He-Ne or InGaAlP lasers with a power range of 10-25 mW demonstrated the most favorable outcomes in preventing and treating OM. PBMT has shown considerable efficacy in reducing the incidence, severity, and pain associated with OM in patients with HNC. Future studies are encouraged to further investigate the most effective parameters for PBMT in the management of OM.
引用
收藏
页码:936 / 950
页数:15
相关论文
共 50 条
  • [1] Efficacy of probiotics in the treatment of oral mucositis in head and neck cancer patients: A systematic review and meta-analysis
    Lin, Peixin
    Zhuang, Jiafeng
    Lai, Jing
    Cui, Ji
    Jiang, Danxian
    Huang, Jing
    [J]. MICROBIAL PATHOGENESIS, 2024, 193
  • [2] Photobiomodulation in oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis followed by a cost-effectiveness analysis
    Thalita Molinos Campos
    Carolina Antunes do Prado Tavares Silva
    Ana Paula Taboada Sobral
    Sergio Sousa Sobral
    Maria Fernanda Setúbal Destro Rodrigues
    Sandra Kalil Bussadori
    Kristianne Porta Santos Fernandes
    Raquel Angnelli Mesquita-Ferrari
    Anna Carolina Ratto Tempestini Horliana
    Lara Jansiski Motta
    [J]. Supportive Care in Cancer, 2020, 28 : 5649 - 5659
  • [3] Photobiomodulation in oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis followed by a cost-effectiveness analysis
    Campos, Thalita Molinos
    do Prado Tavares Silva, Carolina Antunes
    Sobral, Ana Paula Taboada
    Sobral, Sergio Sousa
    Rodrigues, Maria Fernanda Setubal Destro
    Bussadori, Sandra Kalil
    Fernandes, Kristianne Porta Santos
    Mesquita-Ferrari, Raquel Angnelli
    Horliana, Anna Carolina Ratto Tempestini
    Motta, Lara Jansiski
    [J]. SUPPORTIVE CARE IN CANCER, 2020, 28 (12) : 5649 - 5659
  • [4] Efficacy of photobiomodulation in the treatment of oral mucositis in patients undergoing antineoplastic therapy: systematic review and meta-analysis
    Cruz A.R.
    Minicucci E.M.
    Betini M.
    Almeida-Lopes L.
    Tieghi Neto V.
    Cataneo A.J.M.
    [J]. Supportive Care in Cancer, 2023, 31 (11)
  • [5] Biomarkers in the assessment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis
    Ana Gabriela Costa Normando
    Camila Lopes Rocha
    Isabela Porto de Toledo
    Paulo Tadeu de Souza Figueiredo
    Paula Elaine Diniz dos Reis
    Graziela De Luca Canto
    Eliete Neves Silva Guerra
    [J]. Supportive Care in Cancer, 2017, 25 : 2969 - 2988
  • [6] Biomarkers in the assessment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis
    Costa Normando, Ana Gabriela
    Rocha, Camila Lopes
    de Toledo, Isabela Porto
    de Souza Figueiredo, Paulo Tadeu
    Diniz dos Reis, Paula Elaine
    Canto, Graziela De Luca
    Silva Guerra, Eliete Neves
    [J]. SUPPORTIVE CARE IN CANCER, 2017, 25 (09) : 2969 - 2988
  • [7] Effectiveness of glutamine in the management of oral mucositis in cancer patients: a meta-analysis of randomized controlled trials
    Tzu-Rong Peng
    Hung-Hong Lin
    Li-Jou Yang
    Ta-Wei Wu
    [J]. Supportive Care in Cancer, 2021, 29 : 4885 - 4892
  • [8] Role of Glutamine in the Management of Oral Mucositis in Patients with Cancer: A Meta-Analysis of Randomized Controlled Trials
    Tang, Gang
    Huang, Wang
    Zhang, Linyu
    Wei, Zhengqiang
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (02): : 482 - 495
  • [9] Effectiveness of glutamine in the management of oral mucositis in cancer patients: a meta-analysis of randomized controlled trials
    Peng, Tzu-Rong
    Lin, Hung-Hong
    Yang, Li-Jou
    Wu, Ta-Wei
    [J]. SUPPORTIVE CARE IN CANCER, 2021, 29 (08) : 4885 - 4892
  • [10] Prevention and Treatment of Oral Mucositis in Pediatric Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Andriakopoulou, Chrysi Stefania
    Yapijakis, Christos
    Koutelekos, Ioannis
    Perdikaris, Pantelis
    [J]. IN VIVO, 2024, 38 (03): : 1016 - 1029